Exabis Library
Welcome to the e-CCO Library!
P451: Evaluating drug sustainability, efficacy and safety of biologic agents in elderly patients with Inflammatory Bowel Disease: a single center retrospective study
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P451: Long-term surgical outcome of ileal pouch-anal anastomosis when used for well-defined Crohn’s disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P451: Safety and efficacy of ferric carboxymaltose (FCM) for the treatment of iron deficiency anaemia in paediatric patients affected by inflammatory bowel disease (pIBD)
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P451: The efficacy of infliximab in tacrolomus non-responder with ulcerative colitis
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P452 Biologic use patterns and predictors for non-persistence and switching of biologics in patients with inflammatory bowel disease: a nationwide population-based study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P452: Fecal Microbiota Transplantation Leads to Lower IBD Related Complications in Hospitalized Inflammatory Bowel Disease Patients with Clostridioides difficile Infection: A retrospective cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P452: Impact of implementing a rapid access clinic in a high-volume inflammatory bowel disease centre: accessibility, resource utilisation and outcomes
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P452: Medium to long-term outcomes in patients receiving accelerated dose infliximab induction for acute severe ulcerative colitis (ASUC) in a multi-centre cohort
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P452: Oral ciclosporin is a convenient, effective and safe rescue therapy in steroid refractory Acute Severe Ulcerative Colitis: A single tertiary centre experience
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P452: Safety and efficacy of infliximab biosimilar (Remsima©) in Crohn’s disease patients in clinical practice: results after 6 months of treatment
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P452: Silent anaemia predicts treatment change in patients with Crohn's disease in clinical remission
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P452: Tofacitinib Effectiveness and Safety as Therapy for Ulcerative Colitis
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
P453 Comparison of therapeutic effects between groups of thiopurine alone and combination of thiopurine with 5-ASA after remission introduced by oral tacrolimus for patients with severe ulcerative colitis
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P453: Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P453: Golimumab in real-world practice in patients with ulcerative colitis: 2-year interim results from a non-interventional trial in Germany
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P453: Insufficient vaccination and inadequate immunisation rates amongst Korean patients with inflammatory bowel diseases
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
P453: Pre-operative vedolizumab treatment and postoperative complications in patients with inflammatory bowel disease: A systematic review and meta-analysis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P453: The significance of the concentration of antibodies to infliximab on the frequency of loss of response when alternating the original drug infliximab and its biosimilar in patients with ulcerative colitis.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:05 AM
P453: The use of immunosuppresants is associated with high treatment persistence rates for infliximab and adalimumab as first or second line anti-TNF therapy in patients with inflammatory bowel disease
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P453: Underutilisation of novel and alternative oral iron preparations may incur unnecessary cost in iron deficiency anaemia treatment in inflammatory bowel disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM